Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
Abnormal elevation of amyloid β-peptide (Aβ) levels in the brain is the primary trigger for neuronal cell death specific to Alzheimer’s disease (AD). It is now evident that Aβ levels in the brain are manipulable due to a dynamic equilibrium between its production from the amyloid precursor protein (...
Main Authors: | Natalia N Nalivaeva, Nikolai D Belyaev, Caroline eKerridge, Anthony J Turner |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-09-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00235/full |
Similar Items
-
Lipid rafts and Alzheimer’s disease: protein-lipid interactions and perturbation of signalling
by: David A. Hicks, et al.
Published: (2012-06-01) -
APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression
by: Marcus Otto Grimm, et al.
Published: (2015-05-01) -
Axon-Autonomous Effects of the Amyloid Precursor Protein Intracellular Domain (AICD) on Kinase Signaling and Fast Axonal Transport
by: Svenja König, et al.
Published: (2023-10-01) -
Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01) -
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
by: Peedicayil J
Published: (2020-03-01)